Evolution of the Human Immunodeficiency Virus Type 2 Envelope in the First Years of Infection is Associated with the Dynamics of the Neutralizing Antibody Response
Overview
Authors
Affiliations
Background: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4⁺ T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are thought to play a central role in HIV-2 evolution and pathogenesis. However, the dynamic of the Nab response and resulting HIV-2 escape during acute infection and their impact in HIV-2 evolution and disease progression remain largely unknown. Our objective was to characterize the Nab response and the molecular and phenotypic evolution of HIV-2 in association with Nab escape in the first years of infection in two children infected at birth.
Results: CD4⁺ T cells decreased from about 50% to below 30% in both children in the first five years of infection and the infecting R5 viruses were replaced by X4 viruses within the same period. With antiretroviral therapy, viral load in child 1 decreased to undetectable levels and CD4+ T cells recovered to normal levels, which have been sustained at least until the age of 12. In contrast, viral load increased in child 2 and she progressed to AIDS and death at age 9. Beginning in the first year of life, child 1 raised high titers of antibodies that neutralized primary R5 isolates more effectively than X4 isolates, both autologous and heterologous. Child 2 raised a weak X4-specific Nab response that decreased sharply as disease progressed. Rate of evolution, nucleotide and amino acid diversity, and positive selection, were significantly higher in the envelope of child 1 compared to child 2. Rates of R5-to-X4 tropism switch, of V1 and V3 sequence diversification, and of convergence of V3 to a β-hairpin structure were related with rate of escape from the neutralizing antibodies.
Conclusion: Our data suggests that the molecular and phenotypic evolution of the human immunodeficiency virus type 2 envelope are related with the dynamics of the neutralizing antibody response providing further support for a model in which Nabs play an important role in HIV-2 pathogenesis.
Taveira N, Figueiredo I, Calado R, Martin F, Bartolo I, Marcelino J Int J Mol Sci. 2023; 24(10).
PMID: 37240423 PMC: 10219247. DOI: 10.3390/ijms24109077.
Bartolo I, Moranguinho I, Goncalves P, Diniz A, Borrego P, Martin F Int J Mol Sci. 2022; 23(22).
PMID: 36430777 PMC: 9695772. DOI: 10.3390/ijms232214300.
Molecular Biology and Diversification of Human Retroviruses.
Meissner M, Talledge N, Mansky L Front Virol. 2022; 2.
PMID: 35783361 PMC: 9242851. DOI: 10.3389/fviro.2022.872599.
Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2.
Serra P, Taveira N, Guedes R Int J Mol Sci. 2021; 22(4).
PMID: 33669351 PMC: 7920276. DOI: 10.3390/ijms22041948.
Evolution of HIV-1 within untreated individuals and at the population scale in Uganda.
Raghwani J, Redd A, Longosz A, Wu C, Serwadda D, Martens C PLoS Pathog. 2018; 14(7):e1007167.
PMID: 30052678 PMC: 6082572. DOI: 10.1371/journal.ppat.1007167.